181 studies found for:    "Wilms tumor"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Gene Expression Profiles to Categorize Wilms Tumors
Conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Intervention: Other: laboratory biomarker analysis
2 Suspended Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Adult Renal Wilms Tumor;   Beckwith-Wiedemann Syndrome;   Childhood Renal Wilms Tumor;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Hemihypertrophy;   Stage I Renal Wilms Tumor;   Stage II Renal Wilms Tumor;   Stage III Renal Wilms Tumor;   Stage IV Renal Wilms Tumor;   Stage V Renal Wilms Tumor
Interventions: Biological: Dactinomycin;   Drug: Doxorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Etoposide Phosphate;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery;   Procedure: Adjuvant Therapy;   Procedure: Neoadjuvant Therapy
3 Completed Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Conditions: Clear Cell Sarcoma of the Kidney;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Rhabdoid Tumor of the Kidney;   Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
4 Completed Gene Analysis in Studying Susceptibility to Wilms Tumor
Conditions: Recurrent Childhood Kidney Neoplasm;   Stage I Kidney Wilms Tumor;   Stage II Kidney Wilms Tumor;   Stage III Kidney Wilms Tumor;   Stage IV Kidney Wilms Tumor
Intervention: Other: Laboratory Biomarker Analysis
5 Completed Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Conditions: Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor
Interventions: Procedure: therapeutic conventional surgery;   Drug: vincristine sulfate;   Biological: dactinomycin;   Drug: doxorubicin hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
6 Recruiting Collaborative Wilms Tumour Africa Project
Condition: Wilms Tumour
Interventions: Drug: SIOP PODC Wilms tumour treatment: Preoperative chemotherapy;   Procedure: SIOP PODC Wilms tumour treatment: surgery;   Drug: SIOP PODC Wilms tumour treatment: post operative chemotherapy
7 Completed Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Stage III Wilms Tumor
Intervention: Other: laboratory biomarker analysis
8 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Conditions: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q;   Stage IV Wilms Tumor
Interventions: Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Procedure: conventional surgery;   Radiation: 3-dimensional conformal radiation therapy;   Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: etoposide
9 Recruiting Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Conditions: Wilms' Tumor;   Aniridia
Interventions: Behavioral: Questionnaire;   Other: Blood specimen
10 Completed A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor
Condition: Wilms Tumor
Intervention: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim
11 Recruiting Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Conditions: Ewing Sarcoma;   Rhabdomyosarcoma;   Wilms Tumor
Intervention: Radiation: Stereotactic Body Radiotherapy (SBRT)
12 Completed Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Conditions: Denys-Drash Syndrome;   Frasier Syndrome;   Nephrotic Syndrome;   Wilms Tumor
Intervention:
13 Withdrawn National Wilm's Tumor Study Late Effects
Condition: Wilm's Tumor
Intervention: Other: none, screening only
14 Not yet recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Conditions: Adrenal Cortex Carcinoma;   Adult Alveolar Soft Part Sarcoma;   Adult Clear Cell Sarcoma of Soft Parts;   Adult Hepatocellular Carcinoma;   Adult Rhabdomyosarcoma;   Adult Soft Tissue Sarcoma;   Childhood Alveolar Soft Part Sarcoma;   Childhood Central Nervous System Neoplasm;   Childhood Clear Cell Sarcoma of Soft Parts;   Childhood Hepatocellular Carcinoma;   Childhood Rhabdomyosarcoma;   Childhood Soft Tissue Sarcoma;   Childhood Solid Neoplasm;   Ewing Sarcoma;   Hepatoblastoma;   Hepatocellular Carcinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adult Hepatocellular Carcinoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Alveolar Soft Part Sarcoma;   Recurrent Childhood Central Nervous System Neoplasm;   Recurrent Childhood Hepatocellular Carcinoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Renal Cell Carcinoma;   Recurrent Rhabdomyosarcoma;   Relapsed Solid Neoplasm;   Renal Cell Carcinoma;   Thyroid Gland Medullary Carcinoma;   Wilms Tumor
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
15 Recruiting Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Conditions: Pleuropulmonary Blastoma;   Recurrent Malignant Peripheral Nerve Sheath Tumor;   Recurrent Neuroblastoma;   Recurrent Rhabdomyosarcoma;   Recurrent Synovial Sarcoma;   Wilms Tumor
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Lorvotuzumab Mertansine;   Other: Pharmacological Study
16 Completed Biomarkers in Samples From Younger Patients With Wilms Tumor
Condition: Wilms Tumor and Other Childhood Kidney Tumors
Intervention: Other: laboratory biomarker analysis
17 Completed
Has Results
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Conditions: Childhood Hepatocellular Carcinoma;   Papillary Thyroid Cancer;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Liver Cancer;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Thyroid Cancer;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Interventions: Drug: sorafenib tosylate;   Other: pharmacological study;   Other: laboratory biomarker analysis
18 Recruiting Study of Kidney Tumors in Younger Patients
Conditions: Clear Cell Sarcoma of the Kidney;   Congenital Mesoblastic Nephroma;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
19 Completed Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Conditions: Brain and Central Nervous System Tumors;   Hereditary Wilms Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Pleuropulmonary Blastoma;   Sarcoma
Interventions: Genetic: DNA analysis;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
20 Completed A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
Conditions: Nephroblastoma;   Neuroblastoma
Intervention: Drug: IFN-alpha with retinoic acid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years